(1)
Evaluation of Response to Ritlecitinib Treatment Based on SALT Improvement Scores in Patients With Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b 3 Study. J of Skin 2023, 7 (2), s187. https://doi.org/10.25251/skin.7.supp.187.